je.st
news
Tag: sees
MSC Industrial Direct Co Inc (MSM) Sees Unusually-High Trading Volume Following Earnings Beat
2016-01-07 20:45:05| Industrial Machines - Topix.net
MSC Industrial Direct Co Inc shares saw unusually-strong trading volume on Thursday following a stronger than expected earnings report, MarketBeat reports. Approximately 610,372 shares changed hands during mid-day trading, an increase of 10% from the previous session's volume of 556,451 shares.The stock last traded at $60.86 and had previously closed at $60.29.
Tags: direct
volume
industrial
trading
Weekly Cattle Market Wrap-Up | Feeder cattle market sees needed jump
2016-01-07 18:11:00| Beef
Runs had slowed down prior to Christmas as producers waited and hoped for a turn around after the holidays, and they were rewarded with a massive jump which brought a big run of over 30,000 head to our test auctions. Audio File: Beef mag fdr ctl and cow audio 2016 01 07.mp3 read more
Tags: market
jump
needed
weekly
Wall Street sees renewed big falls
2016-01-06 16:04:11| BBC News | Business | UK Edition
Wall Street shares open sharply lower on Wednesday as fears persist over the health of the Chinese economy, with all three main indexes dropping more than 1%.
CEO Frazier: Merck is eager for deals, sees strong prospects for drugs for cancer, hepatitis C
2016-01-05 22:22:53| Biotech - Topix.net
Merck's chief executive says the drugmaker is "raring to go" on deals this year, particularly for small and midsize acquisitions of companies or their experimental drugs. CEO Kenneth Frazier, speaking Tuesday at a Goldman Sachs conference of CEOs of health care companies in Boston, also said he expects more approvals and growing sales from new cancer drug Keytruda.
Tags: strong
deals
cancer
drugs
Actelion Sees Uptravi Price Of $160,000-170,000/Patient
2016-01-05 21:20:32| Biotech - Topix.net
Swiss drug company Actelion expects an average annual per-patient price for its new pulmonary arterial hypertension medicine in the United States of $160,000 to $170,000, before rebates, Chief Operating Officer Otto Schwarz told analysts on Tuesday. The drug, Uptravi, won approval from the U.S. Food and Drug Administration last month and went on sale this week, giving doctors another option to treat the deadly disease that kills victims within a few years.
Tags: price
sees
price sees
sees price
Sites : [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] next »